The Application of Digital Pathology to Improve Accuracy in Glomerular Enumeration in Renal Biopsies by Rosenberg, Avi Z. et al.
RESEARCH ARTICLE
The Application of Digital Pathology to
Improve Accuracy in Glomerular
Enumeration in Renal Biopsies
Avi Z. Rosenberg1,2☯, Matthew Palmer3☯, Lino Merlino4☯, Jonathan P. Troost5,
Adil Gasim6, Serena Bagnasco7, Carmen Avila-Casado8, Duncan Johnstone9, Jeffrey
B. Hodgin10, Catherine Conway11, BrendaW. Gillespie12, Cynthia C. Nast13,
Laura Barisoni4, Stephen M. Hewitt11*
1 Department of Pathology, Children’s National Medical Center, Washington, DC, United States of America,
2 National Institute of Digestive Diseases and Kidney, National Institutes of Health, Bethesda, MD, United
States of America, 3 Department of Pathology, University of Pennsylvania, Philadelphia, PA, United States
of America, 4 Department of Pathology, University of Miami, Miami, FL, United States of America,
5 Department of Pediatrics, Division of Pediatric Nephrology, University of Michigan, Ann Arbor, MI, United
States of America, 6 Department of Pathology, University of North Carolina, Chapel Hill, NC, United States of
America, 7 Department of Pathology, The Johns Hopkins School of Medicine, Baltimore, MD, United States
of America, 8 Department of Pathology, Toronto General Hospital, Toronto, Ontario, Canada, 9 Department
of Medicine, Section of Nephrology, Hypertension and Kidney Transplantation Temple University,
Philadelphia, PA, United States of America, 10 Department of Pathology, University of Michigan, Ann Arbor,
MI, United States of America, 11 Laboratory of Pathology, Center for Cancer Research, National Cancer
Institute, National Institutes of Health, Bethesda, MD, United States of America, 12 Biostatistics Department,
School of Public Health, University of Michigan, Ann Arbor, MI, United States of America, 13 Department of
Pathology, Cedars-Sinai Medical Center, Los Angeles, CA, United States of America
☯ These authors contributed equally to this work.
* genejock@helix.nih.gov
Abstract
Background
In renal biopsy reporting, quantitative measurements, such as glomerular number and per-
centage of globally sclerotic glomeruli, is central to diagnostic accuracy and prognosis. The
aim of this study is to determine the number of glomeruli and percent globally sclerotic in
renal biopsies by means of registration of serial tissue sections and manual enumeration,
compared to the numbers in pathology reports from routine light microscopic assessment.
Design
We reviewed 277 biopsies from the Nephrotic Syndrome Study Network (NEPTUNE) digital
pathology repository, enumerating 9,379 glomeruli by means of whole slide imaging. Glo-
merular number and the percentage of globally sclerotic glomeruli are values routinely
recorded in the official renal biopsy pathology report from the 25 participating centers. Two
general trends in reporting were noted: total number per biopsy or average number per
level/section. Both of these approaches were assessed for their accuracy in comparison to
the analogous numbers of annotated glomeruli on WSI.
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Results
The number of glomeruli annotated was consistently higher than those reported (p<0.001);
this difference was proportional to the number of glomeruli. In contrast, percent globally
sclerotic were similar when calculated on total glomeruli, but greater in FSGS when calcu-
lated on average number of glomeruli (p<0.01). The difference in percent globally sclerotic
between annotated and those recorded in pathology reports was significant when global
sclerosis is greater than 40%.
Conclusions
Although glass slides were not available for direct comparison to whole slide image annota-
tion, this study indicates that routine manual light microscopy assessment of number of glo-
meruli is inaccurate, and the magnitude of this error is proportional to the total number of
glomeruli.
Introduction
The morphologic assessment of renal biopsies is a well-established practice and provides
important diagnostic and prognostic information. Standardized assessment and reporting for
these specimens is essential [1]. Although most renal biopsy diagnoses are dependent on quali-
tative features, semi-quantitative metrics are routinely applied for prognostic measures and
treatment decisions. Semi-quantitative approaches were first introduced in lupus nephritis and
emphasized the detailed evaluation of all lesions in glomerular and tubulointerstitial compart-
ments [2–4]. Subsequently, similar approaches to systematic semi-quantitative biopsy interpre-
tation have been applied to other renal diseases [5–9]. Thus, accuracy in reporting quantitative
and semiquantitative values is emphasized by consensus papers for routine renal pathology
reporting [1, 10]. Renal pathologists report glomerular numbers in renal biopsies utilizing vari-
ous approaches, including a) attempting assessment of the total number of glomeruli by look-
ing at all sections available, b) averaging the number of glomeruli per section either counting
all glomeruli in each levels as individual glomeruli, or by using the level with the most and the
least, c) providing a range using the sections with the least and the most glomeruli. It is, how-
ever, appreciated that there are technical limitations independent of the individual pathologists
experience and accuracy.
The Nephrotic Syndrome Study Network (NEPTUNE) implemented a digital pathology
repository (DPR) that includes whole slide images (WSI) of all kidney biopsy levels available
for each case and a copy of the de-identified pathology report [11]. The NEPTUNE digital
pathology protocol (NDPP), by application of glomerular annotation in discontinuous but
sequential sections, sought to standardize reporting metrics by refining accuracy. The annota-
tion and enumeration of glomeruli in all available WSI sections enables not only the estimation
of the overall number of glomeruli, but also of affected glomeruli by any parameter of choice
[12].
Here, we applied WSI and annotation software to evaluate the most basic quantitative met-
rics: total number of glomeruli and number/percentage of globally sclerotic glomeruli. Addi-
tionally, by comparing the digital quantitative analysis to the manual light microscopy
(LM) analysis as routinely reported, we test its potential value in improving clinical practice.
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Methods
NEPTUNE DPR and case selection
Renal biopsies are an enrollment criteria of the NEPTUNE study (ClinicalTrials.gov Identifier:
NCT01240564). All patients were consented at enrollment, and the study was approved by
Institutional Review Boards of all participating institutions (http://www.rarediseasesnetwork.
org/cms/neptune).
According to the NEPTUNE protocol, all renal biopsies are digitized and together with the
de-identified PDF of the pathology report, stored in the NEPTUNE DPR [11, 13]. From a total
of 392 digital renal biopsies, 317 cases with a diagnosis of minimal change disease (MCD),
focal and segmental glomerulosclerosis (FSGS), membranous glomerulopathy (MN), and IgA
nephropathy (IgAN) were eligible for inclusion in this study. Other glomerular diseases were
excluded. The pdf of the pathology report was reviewed by two pathologists to determine
whether the number of glomeruli and the number of globally sclerotic glomeruli (GS) present
in the biopsy was documented. Cases where the pathology report was missing the glomerular
number assessment (40/317), either as a total number of glomeruli per biopsy as determined
by an assessment across all histology sections, or as an average number of glomeruli per histol-
ogy level, were excluded. A total of 277/317 cases were selected, distributed across the following
diagnosis: 79 MCD, 108 FSGS, 54 MN, and 36 IgAN (Fig 1), all of which contain contained
documentation of the the assessment of GS. No glass slides were available for re-review as part
of this study.
Glomerular counting
To test the value of annotation for glomerular enumeration and counting, ten pathologists
annotated glomeruli in all WSI levels available by remotely accessing the 277 cases stored in
the NEPTUNE DPR (Fig 1). As previously described, annotation of glomeruli was achieved by
visualizing and aligning up to 4 WSI simultaneously (DIH, Leica, Dublin IR) and enumerating
each glomerulus with a unique number that was maintained in all levels examined [11]. (Fig 2)
Following initial annotation, each case underwent quality control review for accuracy of anno-
tation by a different pathologist. Two of the ten pathologists independently retrieved the total
number of annotated glomeruli in all 277 cases by remotely accessing each biopsy WSI sec-
tion/level in the NEPTUNE DPR and recording the highest number used for glomerular
annotation.
To investigate concordance between number of glomeruli counted on annotated WSI and
number of glomeruli reported in the anonymized pathology reports, reported glomerular
count was also recorded by two pathologists either as the absolute total number of glomeruli
(139 cases) or the average of the number of glomeruli per histology level (138 cases). The num-
ber of annotated glomeruli was then compared to the number of reported glomeruli as follow:
a) for the 139 cases where the total number of glomeruli were recorded in the pathology
report, the total number of reported glomeruli per biopsy was compared to the total number of
annotated glomeruli counted on the corresponding WSI; b) for the 138 cases where the average
number of glomeruli per histology level was reported, this average was compared to the average
number of annotated glomeruli per WSI level per biopsy, calculated by dividing the total num-
ber of annotated glomeruli per number of WSI levels in each case.
To investigate the impact of annotation on assessment of globally sclerotic glomeruli, two
pathologists counted the annotated GS by remotely accessing the NEPTUNE DPR and each
biopsy WSI section/level, and recorded the total number or average number of reported GS by
reviewing the report pdf. The number and percentage of annotated GS were compared with
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those recorded in the pathology report. Discrepancy for GS between the two pathologists were
resolved by webinar consensus review. The percentages of annotated globally sclerotic glomer-
uli fromWSI and from the pathology reports were calculated using annotated (total or average)
and reported number of glomeruli, respectively.
Statistical methods
Descriptive statistics including mean, range, median and interquartile range (IQR). Wilcoxon
signed rank tests were used to test the difference in total number and number of globally scle-
rotic glomeruli from annotated WSI versus given in pathology reports. The Wilcoxon test was
used due to non-normality of the paired differences of annotated versus reported glomeruli.
The analysis was performed separately for cases with pathology reports giving total versus
average numbers of glomeruli, and presented both overall and with stratification by diagnosis
(FSGS, MCD, MN, and IgANP).
To estimate the differences between annotated and reported counts and percentages with
global sclerosis by categories of number of glomeruli or percent globally sclerotic glomeruli,
Fig 1. Summary of workflow for case selection and annotation using the NEPTUNE Digital Pathology repository.
doi:10.1371/journal.pone.0156441.g001
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linear regression models were used. The outcomes were the differences between annotated and
reported values, and glomeruli categories were the covariates. All analyses were conducted in
SAS software V9.4 (SAS Institute Inc., Cary, NC, USA).
Results
Assessment of annotated glomeruli on WSI
A total of 9,379 annotated glomeruli were counted, of which 1,322 were classified as globally
sclerotic. Across all four diagnostic categories, the average number of glomeruli per biopsy was
33 with a range of 3 to 164. Percent globally sclerotic averaged 16.7%, with a range of 0 to 100.
Comparison of total number of annotated versus reported glomeruli
For the 139 cases where the total number of discrete glomeruli was given on the pathology
report, the total number of annotated glomeruli per case was higher on average than the total
Fig 2. Digital review and annotation of whole slide images in the NEPTUNE digital pathology repository. A) Example of multiple levels visualized
at the same time. The software allows overlapping and orientation of the sections to facilitate multilevel reconstruction and representation of the biopsy
levels. B) Digital annotation of whole slide images. Two levels are shown in alignment. Glomeruli in the left panel are annotated in red. In a subsequent
level (right panel), two of the red-annotated glomeruli are still present (3 and 4), while one has disappeared (6). Three additional glomeruli, including one
adjacent to glomerulus 3 and 6 have appeared in the deeper level (annotated in blue).
doi:10.1371/journal.pone.0156441.g002
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number of glomeruli reported (Annotated: mean glomeruli per case = 30.7; range 3–149;
median = 23; IQR 13–43. Reported: mean glomeruli per case = 18.3; range 2–71; median = 16;
IQR 10–25; p<0.01) (Table 1). The difference between annotated and reported numbers of glo-
meruli increased as the number of glomeruli increased, with a ratio approaching 2:1 (Fig 3A).
This relationship is also shown in Table 2, where the increase of annotated over reported glo-
meruli is proportional to the number of reported glomeruli.
Comparison of average number of annotated versus reported glomeruli
Similarly, for the 138 cases where the average number of glomeruli per level was given on the
pathology report, the average numbers of annotated glomeruli per level were higher than the
average numbers given on pathology reports (Annotated: mean = 36; range 4–164; median = 30;
IQR 19–46. Reported: mean = 21.4; range 4–125; median = 16; IQR 12–28; p<0.01)(Table 1).
Again, the approximate 2:1 ratio is seen in the scatterplot between annotated and reported
average glomeruli (Fig 3B). The increase in the difference with increasing categories of reported
glomeruli (Table 2) mirrors the effect seen with total glomeruli above.
Stratification by center and disease category
Differences in total and average annotated and reported number of glomeruli were maintained
across the 25 centers (data not shown) and all disease categories. (Fig 3C and 3D; Table 1)
Comparison of annotated versus reported globally sclerotic glomeruli
In the 139 cases where the percentage of globally sclerotic glomeruli was obtained from the
reported total number of glomeruli, there was no significant difference in the mean globally
sclerotic glomeruli percentage determined on annotated WSI (14.4%) and the pathology
reports (13.7%) (Table 3, Fig 4A). In contrast, in cases reporting an average glomerular number
(138 cases), annotation yielded a greater mean globally sclerotic glomeruli percentage com-
pared with the corresponding pathology reports (17.9% vs 15.8%, p<0.01) (Table 3, Fig 4B).
When cases were stratified by disease (Fig 4C and 4D; Table 3), this discrepancy was statisti-
cally significant only in FSGS (29.8% vs 25.8%, p =<0.01). While the overall discrepancy was
Table 1. Number of annotated versus reported glomeruli stratified by diagnosis.
Total Average
Reported Annotated Significance* Reported Annotated Significance*
Overall N = 139 Range 2–71 3–149 <0.01 Overall N = 138 Range 4–125 4–164 <0.01
Mean 18.3 30.7 Mean 21.4 36.0
FSGS N = 40 Range 5–71 5–149 <0.01 FSGS N = 68 Range 4–83 4–164 <0.01
Mean 18.7 29.9 Mean 20.1 35.2
MCD N = 33 Range 4–51 5–106 <0.01 MCD N = 46 Range 4–125 7–163 <0.01
Mean 20.2 38.8 Mean 25.8 42.9
MN N = 37 Range 2–45 3–74 <0.01 MN N = 17 Range 8–34 8–55 <0.01
Mean 17.1 26.8 Mean 19.3 28.2
IGA N = 29 Range 4–38 3–65 <0.01 IGA N = 7 Range 5–21 7–44 <0.01
Mean 16.9 27.6 Mean 13.4 24.0
Total: n = 139 cases and Average: n = 138 cases.
*Wilcoxon signed rank test
doi:10.1371/journal.pone.0156441.t001
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small in the percentage of globally sclerotic glomeruli between annotated WSI and pathology
reports, in cases with> 40% globally sclerotic glomeruli there was a significant underestima-
tion in the biopsy reports by both total and average methodologies (p< 0.01) (Fig 4A and 4B;
Table 4); this effect was evident in FSGS and IGA, particularly for the biopsy reports using
average glomeruli (Fig 4C and 4D).
Fig 3. Digital annotation of whole slide images improves accuracy of glomerular enumeration. (A,B) Scatter plot of annotated glomerular number
versus reported glomerular number by diagnosis in cases reporting (A) total number of glomeruli or (B) average number of glomeruli per level. Dotted
diagonal line shows where annotated = reported, and highlights the increase in number of glomeruli found by annotation. (A: n = 139; B: n = 138). (C,D)
Box plot of annotated glomerular number and reported total glomerular number stratified by diagnosis in cases reporting (C) total number of glomeruli
(n = 139) or (D) average number of glomeruli (n = 139).
doi:10.1371/journal.pone.0156441.g003
Glomerular Counts By Digital Annotation
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Discussion
Glomerular counting is a fundamental metric for renal biopsy providing the denominator for
glomerular involvement in primary and secondary kidney diseases. In this study we evaluated
the NEPTUNE protocol for glomerular annotation to provide a standardized and reliable esti-
mate of number of glomeruli. Although Whole Slide Imaging is not approved for primary
diagnosis in routine pathologic practice in the US [14] it is an enabling technology for the
development and validation of evaluation of information gained from light microscopy. WSI
with and without annotation has been demonstrated to enhance reproducibility of pathology
assessment compared to glass slide review [15–17].
The application of digital annotation facilitates accuracy for renal pathology metric that
cannot be achieved by conventional LM. The accuracy of determining the number of glomeruli
in a given biopsy by LM is limited by visual-spatial memory of the pathologist across multiple
histologic levels. This issue is resolved by the digital software allowing visualization and align-
ment of multiple levels at the same time, facilitating identification of the same or different
glomeruli thru the biopsy. Thus, we found significant differences between the number of
glomeruli reported for routine patient care and obtained by LM evaluation, and the number
of glomeruli identified by digital annotation. We also demonstrated that discrepancy in
Table 2. Difference in glomerular count of number of annotated versus reported glomeruli stratified by number of glomeruli.
Total Average
# glom # cases Mean Δ (annot—report) Significance # glom # cases Mean Δ (annot—report) Significance
1–10 37 3.8[0.1,7.5] 0.05 1–10 27 5.7[0.6,10.9] 0.03
11–20 55 9.0[5.9, 12.0] <0.01 11–20 51 13.5[9.8,17.3] <0.01
21–30 29 20.1[15.9, 24.3] <0.01 21–30 35 15.3[10.7,19.9] <0.01
31–40 12 23.3[16.8,29.9] <0.01 31–40 17 15.8[9.3,22.3] <0.01
>40 6 38.8[29.6,48.1] <0.01 >40 8 46.5[37.0,56.0] <0.01
Total: n = 139 cases and Average: n = 138 cases.
doi:10.1371/journal.pone.0156441.t002
Table 3. Number of annotated versus reported percent globally sclerotic (%GS) stratified by diagnosis.
Total Average
Reported %
GS
Annotated %
GS
Significance* Reported %
GS
Annotated %
GS
Significance*
Overall
N = 139
Range 0–80 0–100 0.71 Overall
N = 138
Range 0–100 0–100 <0.01
Mean 13.7 14.4 Mean 15.8 17.9
FSGS N = 40 Range 0–80 0–65.6 0.99 FSGS N = 68 Range 0–100 0–100 <0.01
Mean 16.6 16.0 Mean 25.8 29.8
MCD N = 33 Range 0–25 0–21.7 <0.01 MCD N = 46 Range 0–15.3 0–14.3 0.81
Mean 3.3 2.1 Mean 1.2 1.3
MN N = 37 Range 0–66.7 0–75 0.65 MN N = 17 Range 0–28.6 0–24.1 0.91
Mean 9.1 8.8 Mean 5.8 6.1
IGA N = 29 Range 0–69.2 0–100 0.02 IGA N = 7 Range 0–68.8 0–72.7 0.69
Mean 27.4 33.3 Mean 37.2 40.6
Total: n = 139 cases and Average: n = 138 cases.
*Wilcoxon signed rank test
doi:10.1371/journal.pone.0156441.t003
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glomerular number increases proportionally to the number of glomeruli present within a
biopsy, demonstrating the limitation of manual light microscopy to accurately determine the
number of glomeruli present. In contrast, the annotated and reported percentages of GS were
generally more similar. However, discrepancies were found within disease subgroups and par-
ticularly for cases with percent GS over 40%, with annotated values showing higher percent
sclerosis in all cases. These data suggest that up to a certain threshold, the discrepancy between
annotated and conventional approaches are probably minimally critical for prognostic factors,
Fig 4. Digital annotation of whole slide imagesmodestly improves accuracy of global glomerular sclerosis enumeration. (A,B) Box plot of
annotated percent (%) globally sclerotic glomeruli and reported %globally sclerotic glomeruli in cases reporting (A) total number of glomeruli (n = 139) or
(B) average number of glomeruli (n = 138). (C,D) Box plot of difference between number of annotated and reported % globally sclerotic glomeruli stratified
by % globally sclerotic glomeruli in cases reporting (C) total number of glomeruli (n = 139) or (D) average number of glomeruli (n = 138).
doi:10.1371/journal.pone.0156441.g004
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but may become relevant for biopsies rich in glomeruli and with significant sclerosis. Glomeru-
lar density and percentage of GS have been discussed as a risk factor in disease progression
[18], IgA [19], risk of progression in membranous glomerulonephritis [20] and obesity-related
glomerulopathy [21]. Thus, accurate assessment with improved numerators and denominators
is essential in improving prognostication.
Accurate glomerular counting is fundamental to determining biopsy adequacy and
improved prognostication. It is anticipated that with digital enumeration of glomeruli, the
binomial distribution of abnormal glomeruli (i.e., with segmental lesions), and thus the num-
ber of glomeruli needed for accurate sampling, will be greater than previously suggested [22].
Although the ultimate proof of the increased accuracy of digital annotation versus conven-
tional light microscopy would be provided by direct comparison of glomerular number esti-
mate on glass slide and annotated WSI, glass slides were not available and we had to rely on
values extracted from the pathology report.
Our study demonstrates the limits of the conventional approach to microscopic examina-
tion of tissue in tasks that require enumeration and integration across multiple tissue sections.
We have carried out this study in the context of glomerular disease that is a part of the NEP-
TUNE protocol. The data demonstrates that low frequency events can be accounted for with
relative accuracy, as demonstrated by both the overall glomerular enumeration as well as per-
cent global sclerosis data. However, as the number of events increases, the inaccuracy of the
estimation increases. With the glomerular number, this reached a level of 2:1 when WSI
and manual microscopy are compared. For percent glomerular sclerosis, inaccurate determina-
tions reached statistical significance at 40%GS. These findings suggest that quantization of the
histopathology of glomerular disease by an intensive approach, utilizing WSI and piecemeal
evaluation of individual glomerular profiles will result in new insights to disease classification,
prognostic markers, and potential markers of response to therapy.
These findings suggest the accuracy of detection is object specific, and that findings for one
object may not generalize to other objects. Although this study was performed within the lim-
ited context of primary glomerular disorders, the findings have broad implications for many
observer-based task where integration across image planes is required. The evaluation of renal
biopsies for other disorders, including diabetes, SLE and transplant are obvious fields of
inquiry, as are renal biopsies of medical conditions of the liver, where portal triads and other
features are routinely enumerated. The overall implications are that there are some conven-
tional approaches that may be enhanced by the adoption of computer-aided diagnostic tools.
Manual review and enumeration of renal biopsies with current tools is time consuming and
complex, however the development of tools to aid the reviewer in a value-added strategy are
underway.
Table 4. Difference in %GS glomeruli between annotated versus reported stratified by number of glomeruli.
Total Average
%GS # cases Mean Δ (annot—report) Significance %GS # cases Mean Δ (annot—report) Significance
0–19% 103 -0.80[-22.5,0.1] 0.30 0–19% 92 -0.20 [-1.4, 1.1] 0.77
20–39% 17 -0.24[-38.4, 3.4] 0.90 20–39% 15 3.0 [-0.2, 6.2] 0.07
40–59% 10 6.5[1.8,11.2] <0.01 40–59% 17 7.5 [4.5, 10.6] <0.01
60–100% 9 12.8[7.7,17.9] <0.01 60–100% 14 10.3 [7.0, 13.7] <0.01
Total: n = 139 cases and Average: n = 138 cases.
doi:10.1371/journal.pone.0156441.t004
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